Literature DB >> 29777820

Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?

Nicole Wake1, Hersh Chandarana2, Henry Rusinek3, Koji Fujimoto4, Linda Moy3, Daniel K Sodickson2, Sungheon Gene Kim2.   

Abstract

INTRODUCTION: Pharmacokinetic parameters derived from dynamic contrast-enhanced MRI (DCE-MRI) data are sensitive to acquisition and post-processing techniques, which makes it difficult to compare results obtained using different methods. In particular, one of the most important factors affecting estimation of model parameters is how to convert MRI signal intensities to contrast agent concentration. The purpose of our study was to quantitatively compare a linear signal-to-concentration conversion (LC) as an approximation and a non-linear conversion (NLC) based on the MRI signal equation, in terms of the accuracy and precision of the pharmacokinetic parameters in T1-weighted DCE-MRI.
MATERIALS AND METHODS: Numerical simulation studies were conducted to compare LC and NLC in terms of the accuracy and precision in contrast kinetic parameter estimation, and to evaluate their dependency on flip angle (FA), pre-contrast T1 (T10) and arterial input function (AIF). In addition, the effect of the conversion method on the diagnostic accuracy was evaluated with 36 breast lesions (19 benign and 17 malignant).
RESULTS: The transfer rate (Ktrans) estimated using LC and measured AIF (mAIF) were up to 38% higher than the true Ktrans values, while the LC Ktrans estimates with the presumed AIF (pAIF) were up to 7% lower than the true Ktrans values, when FA = 45°. When using a small FA, such as 12°, the LC Ktrans with pAIF had least sensitivity to the error in T10 compared to the Ktrans estimated using LC with mAIF, and NLC with pAIF or mAIF. The breast DCE-MRI study showed that both LC and NLC Ktrans were significantly different (p < 0.05) between the malignant and benign lesions. The effect size between benign and malignant values as measured by Cohen's d was 1.06 for LC Ktrans and 1.02 for NLC Ktrans.
CONCLUSION: The present study results show that, when precontrast T1 measurement is not available and a low FA is used for DCE-MRI, the uncertainty in the contrast kinetic parameter estimation can be reduced by using the LC method with pAIF, without compromising the diagnostic accuracy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast agent concentration; Dynamic contrast-enhanced MRI; Perfusion; Pharmacokinetic model

Mesh:

Substances:

Year:  2018        PMID: 29777820      PMCID: PMC6102067          DOI: 10.1016/j.mri.2018.05.007

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  40 in total

1.  Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla.

Authors:  Hanzhang Lu; Chekesha Clingman; Xavier Golay; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2004-09       Impact factor: 4.668

2.  Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model.

Authors:  Thomas E Yankeelov; Jeffrey J Luci; Martin Lepage; Rui Li; Laura Debusk; P Charles Lin; Ronald R Price; John C Gore
Journal:  Magn Reson Imaging       Date:  2005-05       Impact factor: 2.546

3.  Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI.

Authors:  Steven Sourbron; Michael Ingrisch; Axel Siefert; Maximilian Reiser; Karin Herrmann
Journal:  Magn Reson Med       Date:  2009-07       Impact factor: 4.668

Review 4.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

5.  3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.

Authors:  Riham H El Khouli; Katarzyna J Macura; Ihab R Kamel; Michael A Jacobs; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2011-12       Impact factor: 3.959

6.  Uncertainty in MR tracer kinetic parameters and water exchange rates estimated from T1-weighted dynamic contrast enhanced MRI.

Authors:  Jin Zhang; Sungheon Kim
Journal:  Magn Reson Med       Date:  2013-09-04       Impact factor: 4.668

7.  DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility.

Authors:  Shimon Aronhime; Claudia Calcagno; Guido H Jajamovich; Hadrien Arezki Dyvorne; Philip Robson; Douglas Dieterich; M Isabel Fiel; Valérie Martel-Laferriere; Manjil Chatterji; Henry Rusinek; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

8.  The role of dynamic contrast-enhanced MRI in the differential diagnosis of psoriatic and rheumatoid arthritis.

Authors:  Nina F Schwenzer; Ina Kötter; Jörg C Henes; Christina Schraml; Jan Fritz; Claus D Claussen; Marius Horger
Journal:  AJR Am J Roentgenol       Date:  2010-03       Impact factor: 3.959

9.  Dynamic contrast-enhanced magnetic resonance imaging parameters independent of baseline T10 values.

Authors:  Jun-Yu Guo; Wilburn E Reddick; Mark A Rosen; Hee Kwon Song
Journal:  Magn Reson Imaging       Date:  2009-06-25       Impact factor: 2.546

10.  The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.

Authors:  M O Leach; K M Brindle; J L Evelhoch; J R Griffiths; M R Horsman; A Jackson; G C Jayson; I R Judson; M V Knopp; R J Maxwell; D McIntyre; A R Padhani; P Price; R Rathbone; G J Rustin; P S Tofts; G M Tozer; W Vennart; J C Waterton; S R Williams; P Workman
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

View more
  6 in total

1.  Diagnostic Performance of Vascular Permeability and Texture Parameters for Evaluating the Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma.

Authors:  Wenbing Ji; Jian Wang; Rongzhen Zhou; Minke Wang; Weizhen Wang; Peipei Pang; Min Kong; Chao Zhou
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

2.  Assessment of tumor treatment response using active contrast encoding (ACE)-MRI: Comparison with conventional DCE-MRI.

Authors:  Jin Zhang; Kerryanne Winters; Karl Kiser; Mehran Baboli; Sungheon Gene Kim
Journal:  PLoS One       Date:  2020-06-10       Impact factor: 3.240

3.  Theranostic Design of Angiopep-2 Conjugated Hyaluronic Acid Nanoparticles (Thera-ANG-cHANPs) for Dual Targeting and Boosted Imaging of Glioma Cells.

Authors:  Angela Costagliola di Polidoro; Giorgia Zambito; Joost Haeck; Laura Mezzanotte; Martine Lamfers; Paolo Antonio Netti; Enza Torino
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639

4.  Six-dimensional quantitative DCE MR Multitasking of the entire abdomen: Method and application to pancreatic ductal adenocarcinoma.

Authors:  Nan Wang; Srinivas Gaddam; Lixia Wang; Yibin Xie; Zhaoyang Fan; Wensha Yang; Richard Tuli; Simon Lo; Andrew Hendifar; Stephen Pandol; Anthony G Christodoulou; Debiao Li
Journal:  Magn Reson Med       Date:  2020-01-21       Impact factor: 4.668

5.  Simultaneous evaluation of perfusion and morphology using GRASP MRI in hepatic fibrosis.

Authors:  Jeong Hee Yoon; Jeong Min Lee; Mi Hye Yu; Bo Yun Hur; Robert Grimm; Steven Sourbron; Hersh Chandarana; Yohan Son; Susmita Basak; Kyoung-Bun Lee; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Eur Radiol       Date:  2021-06-12       Impact factor: 5.315

6.  Assessment of metastatic lymph nodes in head and neck squamous cell carcinomas using simultaneous 18F-FDG-PET and MRI.

Authors:  Jenny Chen; Mari Hagiwara; Babak Givi; Brian Schmidt; Cheng Liu; Qi Chen; Jean Logan; Artem Mikheev; Henry Rusinek; Sungheon Gene Kim
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.